Metabolic Implications of Menopause

ABSTRACT

The incidence of metabolic syndrome increases substantially during perimenopause and early menopause. Postmenopausal women are at a higher risk of hypertension, proatherogenic lipid changes, diabetes, and severe cardiovascular disease as compared with their premenopausal counterparts. Whether or not menopause has a causative contribution to the deteriorating metabolic profile that is independent of chronological aging has been a subject of many studies. Menopausal transition is associated with significant weight gain (2 to 2.5 kg over 3 years on average), which is not dissimilar to that in premenopausal women of like age. Concomitantly, there is an increase in abdominal adiposity and a decrease in energy expenditure, phenomena that have been postulated to explain the higher risk of metabolic syndrome and increases in cholesterol and triglycerides. Hypertension and diabetes become more prevalent with age and should be timely diagnosed and treated. Lifestyle changes including moderately decreased caloric intake and aerobic exercise could prevent proatherogenic changes and weight gain observed with aging. Accurate prediction of cardiovascular risk in midlife women is essential to help identify the subset of women who are likely to benefit from intensive management of metabolic risk factors. This review focuses on metabolic changes associated with menopausal transition, specifically alterations in weight, waist circumference, body fat distribution, energy expenditure, and circulating biomarkers including adipokines.

KEYWORDS

Menopause - obesity - metabolic syndrome - cardiovascular risk

REFERENCES

• 1 Abdel-Halim R E. Obesity: 1000 years ago.  Lancet. 2005;  366(9481) 204
• 2 Matthews K A, Meilahn E, Kuller L H, Kelsey S F, Caggiula A W, Wing R R. Menopause and risk factors for coronary heart disease.  N Engl J Med. 1989;  321(10) 641-646
• 3 Gordon T, Kannel W B, Hjortland M C, McNamara P M. Menopause and coronary heart disease. The Framingham Study.  Ann Intern Med. 1978;  89(2) 157-161
• 4 Lerner D J, Kannel W B. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population.  Am Heart J. 1986;  111(2) 383-390
• 5 Kannel W B, Levy D. Menopause, hormones, and cardiovascular vulnerability in women.  Arch Intern Med. 2004;  164(5) 479-481
• 6 Guthrie J R, Taffe J R, Lehert P, Burger H G, Dennerstein L. Association between hormonal changes at menopause and the risk of a coronary event: a longitudinal study.  Menopause. 2004;  11(3) 315-322
• 7 Matthews K A, Santoro N, Lasley B et al. Relation of cardiovascular risk factors in women approaching menopause to menstrual cycle characteristics and reproductive hormones in the follicular and luteal phases.  J Clin Endocrinol Metab. 2006;  91(5) 1789-1795
• 8 Janssen I, Powell L H, Crawford S, Lasley B, Sutton-Tyrrell K. Menopause and the metabolic syndrome: the Study of Women's Health across the Nation.  Arch Intern Med. 2008;  168(14) 1568-1575
• 9 Janssen I. Influence of age on the relation between waist circumference and cardiometabolic risk markers.  Nutr Metab Cardiovasc Dis. 2009;  19(3) 163-169
• 10 Pasquali R, Casimirri F, Labate A M The VMH Collaborative Group et al. Body weight, fat distribution and the menopausal status in women.  Int J Obes Relat Metab Disord. 1994;  18(9) 614-621
• 11 Matthews K A, Abrams B, Crawford S et al. Body mass index in mid-life women: relative influence of menopause, hormone use, and ethnicity.  Int J Obes Relat Metab Disord. 2001;  25(6) 863-873
• 12 Derby C A, Crawford S L, Pasternak R C, Sowers M, Sternfeld B, Matthews K A. Lipid changes during the menopause transition in relation to age and weight: the Study of Women's Health across the Nation.  Am J Epidemiol. 2009;  169(11) 1352-1361
• 13 Wing R R, Matthews K A, Kuller L H, Meilahn E N, Plantinga P L. Weight gain at the time of menopause.  Arch Intern Med. 1991;  151(1) 97-102
• 14 Sherman B M, West J H, Korenman S G. The menopausal transition: analysis of LH, FSH, estradiol, and progesterone concentrations during menstrual cycles of older women.  J Clin Endocrinol Metab. 1976;  42(4) 629-636
• 15 Weinberg M E, Manson J E, Buring J E et al. Low sex hormone-binding globulin is associated with the metabolic syndrome in postmenopausal women.  Metabolism. 2006;  55(11) 1473-1480
• 16 Chahal H S, Drake W M. The endocrine system and ageing.  J Pathol. 2007;  211(2) 173-180
• 17 Soules M R, Sherman S, Parrott E et al. Executive summary: Stages of Reproductive Aging Workshop (STRAW).  Fertil Steril. 2001;  76(5) 874-878
• 18 Ogden C L, Carroll M D, Curtin L R, McDowell M A, Tabak C J, Flegal K M. Prevalence of overweight and obesity in the United States, 1999–2004.  JAMA. 2006;  295(13) 1549-1555
• 19 Espeland M A, Stefanick M L, Kritz-Silverstein D Postmenopausal Estrogen-Progestin Interventions Study Investigators et al. Effect of postmenopausal hormone therapy on body weight and waist and hip girths.  J Clin Endocrinol Metab. 1997;  82(5) 1549-1556
• 20 Kritz-Silverstein D, Barrett-Connor E. Long-term postmenopausal hormone use, obesity, and fat distribution in older women.  JAMA. 1996;  275(1) 46-49
• 21 Sternfeld B, Wang H, Quesenberry Jr C P et al.. Physical activity and changes in weight and waist circumference in midlife women: findings from the Study of Women's Health across the Nation.  Am J Epidemiol. 2004;  160(9) 912-922
• 22 Macdonald H M, New S A, Campbell M K, Reid D M. Longitudinal changes in weight in perimenopausal and early postmenopausal women: effects of dietary energy intake, energy expenditure, dietary calcium intake and hormone replacement therapy.  Int J Obes Relat Metab Disord. 2003;  27(6) 669-676
• 23 Lovejoy J C, Champagne C M, de Jonge L, Xie H, Smith S R. Increased visceral fat and decreased energy expenditure during the menopausal transition.  Int J Obes (Lond). 2008;  32(6) 949-958
• 24 Lovejoy J C. Weight gain in women at midlife: the influence of menopause.  Obesity Management. 2009;  5 52-56
• 25 Polotsky A J, Santoro N. Menopause and cardiovascular disease: endogenous reproductive hormone exposure affects risk factors.  Menopause Manage. 2007;  16(2) 21-25
• 26 Shimokata H, Andres R, Coon P J, Elahi D, Muller D C, Tobin J D. Studies in the distribution of body fat. II. Longitudinal effects of change in weight.  Int J Obes. 1989;  13(4) 455-464
• 27 Ley C J, Lees B, Stevenson J C. Sex- and menopause-associated changes in body-fat distribution.  Am J Clin Nutr. 1992;  55(5) 950-954
• 28 Franklin R M, Ploutz-Snyder L, Kanaley J A. Longitudinal changes in abdominal fat distribution with menopause.  Metabolism. 2009;  58(3) 311-315
• 29 Berg A H, Scherer P E. Adipose tissue, inflammation, and cardiovascular disease.  Circ Res. 2005;  96(9) 939-949
• 30 Winzer C, Wagner O, Festa A et al. Plasma adiponectin, insulin sensitivity, and subclinical inflammation in women with prior gestational diabetes mellitus.  Diabetes Care. 2004;  27(7) 1721-1727
• 31 Gustafson B, Hammarstedt A, Andersson C X, Smith U. Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis.  Arterioscler Thromb Vasc Biol. 2007;  27(11) 2276-2283
• 32 Lee C G, Carr M C, Murdoch S J et al. Adipokines, inflammation, and visceral adiposity across the menopausal transition: a prospective study.  J Clin Endocrinol Metab. 2009;  94(4) 1104-1110
• 33 Grundy S M. Metabolic syndrome: a multiplex cardiovascular risk factor.  J Clin Endocrinol Metab. 2007;  92(2) 399-404
• 34 Kahn R, Buse J, Ferrannini E, Stern M. American Diabetes Association . The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes.  Diabetes Care. 2005;  28(9) 2289-2304
• 35 Nilsson P M. Cardiovascular risk in the metabolic syndrome: fact or fiction?.  Curr Cardiol Rep. 2007;  9(6) 479-485
• 36 Alberti K GMMF, Eckel R HMDF, Grundy S MMDPF International Diabetes Federation Task Force on Epidemiology and Prevention et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity.  Circulation. 2009;  120(16) 1640-1645
• 37 Ford E S, Giles W H, Mokdad A H. Increasing prevalence of the metabolic syndrome among U.S. adults.  Diabetes Care. 2004;  27(10) 2444-2449
• 38 Bauersachs R, Lindhoff-Last E. Anticoagulation of pregnant women with mechanical heart valves using low-molecular-weight heparin.  Arch Intern Med. 2003;  163(22) 2788-2789
• 39 Carr M C. The emergence of the metabolic syndrome with menopause.  J Clin Endocrinol Metab. 2003;  88(6) 2404-2411
• 40 Frayn K N. Visceral fat and insulin resistance—causative or correlative?.  Br J Nutr. 2000;  83(Suppl 1) S71-S77
• 41 Weinberg M E, Manson J E, Buring J E et al. Low sex hormone-binding globulin is associated with the metabolic syndrome in postmenopausal women.  Metabolism. 2006;  55(11) 1473-1480
• 42 Janssen I, Powell L H, Crawford S, Lasley B, Sutton-Tyrrell K. Menopause and the metabolic syndrome: the Study of Women's Health across the Nation.  Arch Intern Med. 2008;  168(14) 1568-1575
• 43 Torréns J I, Sutton-Tyrrell K, Zhao X et al. Relative androgen excess during the menopausal transition predicts incident metabolic syndrome in midlife women: study of Women's Health across the Nation.  Menopause. 2009;  16(2) 257-264
• 44 Mokdad A H, Ford E S, Bowman B A et al. Diabetes trends in the U.S.: 1990–1998.  Diabetes Care. 2000;  23(9) 1278-1283
• 45a Department of Health ad Human Services Centers for Disease Control and Prevention .National diabetes fact sheet 2007. Available at: http://www.cdc.gov/diabetes/pubs/factsheet07.htm Accessed July 22, 2010
• 45b American Diabetes Association . Diagnosis and classification of diabetes mellitus.  Diabetes Care. 2009;  32(Suppl 1) 62-67
• 46 Sites C K, Calles-Escandón J, Brochu M, Butterfield M, Ashikaga T, Poehlman E T. Relation of regional fat distribution to insulin sensitivity in postmenopausal women.  Fertil Steril. 2000;  73(1) 61-65
• 47 Campbell A J, Busby W J, Horwath C C, Robertson M C. Relation of age, exercise, anthropometric measurements, and diet with glucose and insulin levels in a population aged 70 years and over.  Am J Epidemiol. 1993;  138(9) 688-696
• 48 Szmuilowicz E D, Stuenkel C A, Seely E W. Influence of menopause on diabetes and diabetes risk.  Nat Rev Endocrinol. 2009;  5(10) 553-558
• 49 Muscelli E, Kozàkovà M, Flyvbjerg A RISC investigators et al. The effect of menopause on carotid artery remodeling, insulin sensitivity, and plasma adiponectin in healthy women.  Am J Hypertens. 2009;  22(4) 364-370
• 50 Soriguer F, Morcillo S, Hernando V et al. Type 2 diabetes mellitus and other cardiovascular risk factors are no more common during menopause: longitudinal study.  Menopause. 2009;  16(4) 817-821
• 51 Dorman J S, Steenkiste A R, Foley T P Familial Autoimmune and Diabetes (FAD) Study et al. Menopause in type 1 diabetic women: is it premature?.  Diabetes. 2001;  50(8) 1857-1862
• 52 Malacara J M, Huerta R, Rivera B, Esparza S, Fajardo M E. Menopause in normal and uncomplicated NIDDM women: physical and emotional symptoms and hormone profile.  Maturitas. 1997;  28(1) 35-45
• 53 López-López R, Huerta R, Malacara J M. Age at menopause in women with type 2 diabetes mellitus.  Menopause. 1999;  6(2) 174-178
• 54 Verhaeghe J. Menopause care for obese and diabetic women.  Facts Views Vision Obgyn. 2009;  1(2) 142-152
• 55 Korytkowski M T, Krug E I, Daly M A, Deriso L, Wilson J W, Winters S J. Does androgen excess contribute to the cardiovascular risk profile in postmenopausal women with type 2 diabetes?.  Metabolism. 2005;  54(12) 1626-1631
• 56 Wajchenberg B L. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome.  Endocr Rev. 2000;  21(6) 697-738
• 57 Middelberg R P, Spector T D, Swaminathan R, Snieder H. Genetic and environmental influences on lipids, lipoproteins, and apolipoproteins: effects of menopause.  Arterioscler Thromb Vasc Biol. 2002;  22(7) 1142-1147
• 58 Mackey R H, Kuller L H, Sutton-Tyrrell K, Evans R W, Holubkov R, Matthews K A. Lipoprotein subclasses and coronary artery calcium in postmenopausal women from the healthy women study.  Am J Cardiol. 2002;  90(8A, 8A) 71i-76i
• 59 Hokanson J E, Austin M A. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies.  J Cardiovasc Risk. 1996;  3(2) 213-219
• 60 Coylewright M, Reckelhoff J F, Ouyang P. Menopause and hypertension: an age-old debate.  Hypertension. 2008;  51(4) 952-959
• 61 Stampfer M J, Colditz G A, Willett W C. Menopause and heart disease. A review.  Ann N Y Acad Sci. 1990;  592 193-203, discussion 257–262
• 62 Izumi Y, Matsumoto K, Ozawa Y et al. Effect of age at menopause on blood pressure in postmenopausal women.  Am J Hypertens. 2007;  20(10) 1045-1050
• 63 Barton M, Meyer M R. Postmenopausal hypertension: mechanisms and therapy.  Hypertension. 2009;  54(1) 11-18
• 64 Kannel W B. Metabolic risk factors for coronary heart disease in women: perspective from the Framingham Study.  Am Heart J. 1987;  114(2) 413-419
• 65 Schillaci G, Verdecchia P, Borgioni C, Ciucci A, Porcellati C. Early cardiac changes after menopause.  Hypertension. 1998;  32(4) 764-769
• 66 Byington R P, Davis B R, Plehn J F et al. Reduction of stroke events with pravastatin: the Prospective Pravastatin Pooling (PPP) Project.  Circulation. 2001;  103(3) 387-392
• 67 Collins P, Rosano G, Casey C et al. Management of cardiovascular risk in the peri-menopausal woman: a consensus statement of European cardiologists and gynaecologists.  Eur Heart J. 2007;  28(16) 2028-2040
• 68 Guthrie J R, Taffe J R, Lehert P, Burger H G, Dennerstein L. Association between hormonal changes at menopause and the risk of a coronary event: a longitudinal study.  Menopause. 2004;  11(3) 315-322
• 69 Kannel W B, Dawber T R, Kagan A, Revotskie N, Stokes III J. Factors of risk in the development of coronary heart disease—six year follow-up experience. The Framingham Study.  Ann Intern Med. 1961;  55 33-50
• 70 Khot U N, Khot M B, Bajzer C T et al. Prevalence of conventional risk factors in patients with coronary heart disease.  JAMA. 2003;  290(7) 898-904
• 71 Ridker P M, Buring J E, Rifai N, Cook N R. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score.  JAMA. 2007;  297(6) 611-619
• 72 Cuff D J, Meneilly G S, Martin A, Ignaszewski A, Tildesley H D, Frohlich J J. Effective exercise modality to reduce insulin resistance in women with type 2 diabetes.  Diabetes Care. 2003;  26(11) 2977-2982
• 73 Bergström I, Lombardo C, Brinck J. Physical training decreases waist circumference in postmenopausal borderline overweight women.  Acta Obstet Gynecol Scand. 2009;  88(3) 308-313
• 74 Kuller L H, Simkin-Silverman L R, Wing R R, Meilahn E N, Ives D G. Women's Healthy Lifestyle Project: a randomized clinical trial: results at 54 months.  Circulation. 2001;  103(1) 32-37
• 75 Simkin-Silverman L R, Wing R R, Boraz M A, Kuller L H. Lifestyle intervention can prevent weight gain during menopause: results from a 5-year randomized clinical trial.  Ann Behav Med. 2003;  26(3) 212-220
• 76 Knowler W C, Barrett-Connor E, Fowler S E Diabetes Prevention Program Research Group et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.  N Engl J Med. 2002;  346(6) 393-403
• 77 National Institutes of Health . Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults–the evidence report.  Obes Res. 1998;  6(Suppl 2) 51S-209S